Cascade AI | $3,750,000 | (Oct 25, 2024)
Mave | $1,444,304 | (Oct 25, 2024)
Outrider | $62,000,000 | (Oct 25, 2024)
Certified by Founder
Lodge
Passkey Therapeutics
start up
United States
- Cambridge, MA
- 22/10/2024
- Seed
- $20,000,000
Passkey Therapeutics is pioneering a new class of medicines, Synergistic Multifunctional Therapeutics or SMThs, designed to address complex diseases by targeting rare combinations of proteins that work together. Using its proprietary Locksmith platform, the company is advancing programs across multiple therapeutic areas to create new options for patients with common, hard-to-treat conditions.
- Industry Biotechnology Research
- Website https://passkeytx.com/
- LinkedIn https://www.linkedin.com/company/passkey-therapeutics/
Related People
Bruce BeutelCo Founder
United States -
Greater Boston
Leadership experience in novel therapeutics and platform research, business development, and company creation. Focused on strategy, vision, team building and value creation at the interface of science and business, particularly for seed through Series A stage biotech.
OLOID | $6,000,000 | (Oct 25, 2024)
MoneyStack | $250,000 | (Oct 25, 2024)
Attention | $14,000,000 | (Oct 25, 2024)
BuildPass | $7,500,000 | (Oct 25, 2024)
Aether Energy (YC W24) | $2,500,000 | (Oct 25, 2024)
Adden Energy | $15,000,000 | (Oct 24, 2024)
Genie AI | $17,190,848 | (Oct 24, 2024)
Valon | $100,000,000 | (Oct 24, 2024)
Fixify | $25,000,000 | (Oct 24, 2024)